Photo Source: NCI Scientists are ready to trial a new cancer vaccine in humans following the successful outcome of their preclinical studies. The new vaccine was developed by a Mater Research team based at The Translational Research Institute in collaboration with The University of Queensland. Lead Researcher Associate Professor Kristen Radford says the vaccine has the potential to treat a variety...
↧